EUVIMEDEUVIMED entdecken
Crossref

Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation

Milena Ivanova iD, Anastasia Ormandjieva, Rumyana Dodova, Radka Kaneva, Velizar Shivarov iD

International Journal of Immunogenetics · 2023

DOI: 10.1111/iji.12631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2023. Verfasst von Milena Ivanova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, University Hospital Alexandrovska, Medical University Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Science Fund, Ministry of Education and Science (MES) of Bulgaria, Biobanking at Molecular Medicine Center, MES of Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study provides the first immunogenetic preliminary evidence that specific human leucocyte antigen (HLA) class I and class II alleles and haplotypes may be relevant for BRCA1 c.5263_5264insC driven oncogenesis. Observed HLA associations might have practical implications for establishment of predictive markers for the response to immunotherapies in malignancies driven by this germ‐line mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histocompatibility Antigens Class INeoplasmsHumansHaplotypesGerm-Line MutationAllelesHistocompatibility Antigens Class IIBRCA1 Protein

Stichwörter der Autor:innen

BCRA1 mutationHLA class IHLA class IIbreast cancerovarian cancer

Substanzen

Histocompatibility Antigens Class IHistocompatibility Antigens Class IIBRCA1 protein, humanBRCA1 Protein

Autor:innen und Institutionen

  • Department of Clinical Immunology, University Hospital Alexandrovska, Medical University Sofia, Sofia, Bulgaria.
  • Center for Molecular Medicine, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University Sofia, Sofia, Bulgaria.
  • Department of Experimental Research, Medical University Pleven, Pleven, Bulgaria.

ORCID-Profile: Milena Ivanova, Velizar Shivarov

Förderung

  • National Science Fund, Ministry of Education and Science (MES) of Bulgaria
  • Biobanking at Molecular Medicine Center
  • MES of Bulgaria

Zitieren

APA

Ivanova, M., Ormandjieva, A., Dodova, R., Kaneva, R., & Shivarov, V. (2023). Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation. International Journal of Immunogenetics. https://doi.org/10.1111/iji.12631

Vancouver

Ivanova M, Ormandjieva A, Dodova R, Kaneva R, Shivarov V. Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation. International Journal of Immunogenetics. 2023. doi:10.1111/iji.12631

BibTeX
@article{Ivanova2023,
  author = {Ivanova, Milena and Ormandjieva, Anastasia and Dodova, Rumyana and Kaneva, Radka and Shivarov, Velizar},
  title = {Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation},
  journal = {International Journal of Immunogenetics},
  year = {2023},
  doi = {10.1111/iji.12631}
}
Kostenlos starten →